bimoclomol

The novel hydroxylamine derivative, bimoclomol, has been shown previously to act as a co-inducer of several heat shock proteins… Expand

The hydroxylamine derivative bimoclomol (BM) has been shown to activate natural cytoprotective homeostatic responses by enhancing… Expand

Bimoclomol has been shown to increase an inducible member of the heat shock protein 70 family (HSP70) and cytoprotect in vitro… Expand

Bimoclomol (BML), a symptomatic antidiabetic agent, has been developed by Biorex R & D Co. to treat diabetic neuropathy and… Expand

Bimoclomol, the recently developed non-toxic heat shock protein (HSP) coinducer, was shown to display multilateral protective… Expand

Abstract. Concentration-dependent effects of bimoclomol, a novel heat shock protein (HSP) coinducer, were studied on the… Expand

A silent process involving both neural and vascular structures in diabetic retina persists for several years before clinically… Expand

Bimoclomol (BRLP-42) is a novel antiischemic compound acting against peripheral vascular complications of diabetes mellitus… Expand

Preservation of the chemical architecture of a cell or of an organism under changing and perhaps stressful conditions is termed… Expand

A reduction in nerve conduction velocity and an increase in resistance to ischemic conduction failure are early signs of neural… Expand